© 2022 MJH Life Sciences and Drug Topics. All rights reserved.
February 23, 2022
An expert panel discusses where bempedoic acid currently fits into the treatment of hypercholesterolemia.
February 16, 2022
An overview of the REDUCE-IT trial of icosapent ethyl for the management of triglycerides and prevention of cardiovascular events.
February 09, 2022
The role of ezetimibe and PCSK9 inhibitors as treatment for patients who are statin intolerant or require add-on therapy to help reduce cholesterol levels.
January 14, 2022
The standard of care for managing high cholesterol levels.
The value of interdisciplinary research and multidisciplinary care of patients at high risk for cardiovascular events.